Cost-Effectiveness Analysis of Switching Antipsychotic Medication to Long-Acting Injectable Risperidone in Patients with Schizophrenia: A 12- and 24-Month Follow-Up from the e-STAR Database in Spain

By Olivares José M.  

Applied Health Economics and Health Policy, Vol. 6, Iss. 1, 2008-01 ,pp. : 41-53

Adis International

Access to resources Recommend Favorite

Management of Schizophrenia: Defining the Role of Long-Acting Injectable Risperidone

By Curran Monique P.   Keating Gillian M.  

Disease Management & Health Outcomes, Vol. 14, Iss. 2, 2006-01 ,pp. : 107-125

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Antiretrovirals - Long Term or Short Term?

By Flessa Steffen  

Applied Health Economics and Health Policy, Vol. 7, Iss. 4, 2009-12 ,pp. : 225-227

Adis International

Access to resources Recommend Favorite

The cost of hepatitis C and the cost-effectiveness of its prevention

By Shiell A.   Law M.G.  

Health Policy, Vol. 58, Iss. 2, 2001-11 ,pp. : 121-131

Elsevier

Access to resources Recommend Favorite

The cost effectiveness of renal provision in the UK

By Haycox Alan   Jones Diane  

Journal of Management in Medicine, Vol. 10, Iss. 1, 1996-01 ,pp. : 6-15

Emerald Group Publishing Ltd

Access to resources Recommend Favorite